Patent for growth factor boosts Interpore:
This article was originally published in Clinica
Interpore Cross International's research partner Quantic Biomedical has received a US patent for a safe, low-cost method for producing growth factors from a patient's own blood to help heal wounds. Interpore is investigating the use of autologous growth factors for stimulating new bone and cartilage to grow and has recently received 510(k) clearance to market the apparatus for purifying and delivering the growth factors mixed in with a bone graft.
You may also be interested in...
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.
Lilly has launched a similar antibody product, but demand is expected to outpace supply for the foreseeable future.